These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. Gotto AM; Brinton EA J Am Coll Cardiol; 2004 Mar; 43(5):717-24. PubMed ID: 14998606 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hypercholesterolemia in patients with known coronary artery disease. Schlant RC Heart Dis Stroke; 1993; 2(5):373-6. PubMed ID: 8137037 [No Abstract] [Full Text] [Related]
8. The total and HDL-cholesterol levels in populations of St. Petersburg (Russia) and Leipzig (Germany). Plavinski SL; Plavinskaya SI; Richter V; Rassoul F; Schilow W; Klimov AN Nutr Metab Cardiovasc Dis; 1999 Aug; 9(4):184-91. PubMed ID: 10614060 [TBL] [Abstract][Full Text] [Related]
10. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?]. MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232 [No Abstract] [Full Text] [Related]
11. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses? Watts GF Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879 [No Abstract] [Full Text] [Related]
12. [The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis]. Caruzzo C; Carnaghi R; Enrico-Bena L; De Marco G Minerva Med; 1969 Nov; 60(91):4514-8. PubMed ID: 5357297 [No Abstract] [Full Text] [Related]
13. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?]. Windler E Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000 [No Abstract] [Full Text] [Related]
14. The imperative to raise low levels of high-density lipoprotein in cholesterol--a better clinical strategy in the prevention and treatment of coronary artery disease. Introduction. Pearson TA; Boden WE Am J Cardiol; 2000 Dec; 86(12A):1L-4L. PubMed ID: 11374851 [No Abstract] [Full Text] [Related]
15. [Atherosclerosis and blood lipoproteins]. Faergeman O Ugeskr Laeger; 2001 May; 163(21):2924-6. PubMed ID: 11402971 [No Abstract] [Full Text] [Related]
16. [Apolipoproteins in atherosclerosis]. Carino C; Rauseo R; Tiboni GM; De Martiis M Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762 [No Abstract] [Full Text] [Related]
17. Epidemiological studies on cardiovascular risk factors during childhood: total and HDL cholesterol in relation to diet. Knuiman JT; West CE Prog Clin Biol Res; 1985; 188():139-44. PubMed ID: 4059255 [No Abstract] [Full Text] [Related]
18. [Cholesterol: how and when to treat it?]. Masana MarĂn L Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497 [No Abstract] [Full Text] [Related]
19. Safety of anacetrapib in patients with or at high risk for coronary heart disease. Cannon CP; Shah S; Dansky HM; Davidson M; Brinton EA; Gotto AM; Stepanavage M; Liu SX; Gibbons P; Ashraf TB; Zafarino J; Mitchel Y; Barter P; N Engl J Med; 2010 Dec; 363(25):2406-15. PubMed ID: 21082868 [TBL] [Abstract][Full Text] [Related]
20. [Lipid therapy. Goal and use in prevention of coronary heart disease]. Windler E; Greten H Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925 [No Abstract] [Full Text] [Related] [Next] [New Search]